Nova Biogenetics, Inc. Enters Into Remediation Joint Venture Agreement

ATLANTA--(BUSINESS WIRE)--Feb. 16, 2006--Nova BioGenetics, Inc. (OTC: NVBG), a U.S. antimicrobial manufacturer, announces that in the aftermath of Hurricane Katrina and other natural disasters, the demand for Nova's patented EPA approved and registered antimicrobial products has grown dramatically. As a result, the company has recently concluded a joint venture agreement that makes its technology available to the commercial remediation industry across the United States. Certified remediation specialists will use only EPA registered products.